Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
69,579
Sort by:
Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...
May 2022
53 pages
Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Mole...
May 2022
37 pages
Travelers Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Travelers Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Traveler's Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key P...
May 2022
41 pages
Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA,...
May 2022
81 pages
Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
133 pages
Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
46 pages
Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
US$ 3,500.00
Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...
May 2022
247 pages
Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
35 pages
Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...
May 2022
57 pages
Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Mole...
May 2022
41 pages
Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...
May 2022
70 pages
Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
40 pages
Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
64 pages
Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
132 pages
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Devel...
May 2022
36 pages
Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target,...
May 2022
74 pages
Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
45 pages
Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
38 pages
Venezuelan Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Venezuelan Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Venezuelan Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA,...
May 2022
42 pages
Venous Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Venous Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Venous Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
59 pages
Venous (Vein) Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Venous (Vein) Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Venous (Vein) Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
49 pages
Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA,...
May 2022
43 pages
Visceral Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Visceral Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Visceral Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
70 pages
Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...
May 2022
44 pages
